Gene · 1948
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative transcriptomic analysis identifies synovium-derived biomarkers for OA-related synovitis and builds a validated diagnostic nomogram. | Medicine (Baltimore) | 2026 | 41760060 | PubTator, text mining | PubMed |
| Identification of ephrin-A1-EphA2 signalling as a potential target for fracture prevention. | Nat Commun | 2026 | 41723149 | PubTator, text mining | PubMed |
| Something Old, Something New, Something Borrowed… About the Placenta. | Epigenomes | 2026 | 41718403 | PubTator, text mining | PubMed |
| An Evolutionary Distinct Nipah Virus N-Glycosylation Site Provides Stability for Receptor Engagement. | Mol Cell Proteomics | 2026 | 41713789 | PubTator, text mining | PubMed |
| Identification of novel target of quinazolinones active molecules and bioactivity & labeling preference of photocrosslinkers. | Bioorg Chem | 2026 | 41707386 | PubTator, text mining | PubMed |
| Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm. | PLoS Comput Biol | 2026 | 41701761 | PubTator, text mining | PubMed |
| Bioengineering of extracellular vesicles with scaffold proteins for drug delivery. | J Nanobiotechnology | 2026 | 41680844 | PubTator, text mining | PubMed |
| Current advances of bone homeostasis imbalance in the cause of hereditary metabolic bone diseases. | EFORT Open Rev | 2026 | 41636248 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy. | Cell Death Dis | 2026 | 41633975 | PubTator, text mining | PubMed |
| Recovery from apoptosis in photoreceptor cells: A role for mitophagy. | Cell Death Dis | 2026 | 41617676 | PubTator, text mining | PubMed |
| In silico characterization of G protein-host receptor interactions in Bangladesh Nipah virus mutants toward therapeutic target identification. | In Silico Pharmacol | 2026 | 41613644 | PubTator, text mining | PubMed |
| EphrinB2 Regulates DPSC Pericyte-like Functions via the Focal Adhesion Pathway. | J Dent Res | 2026 | 41560563 | PubTator, text mining | PubMed |
| Regarding: 'The Role of EphrinB2-EphB4 Signalling Pathway in Regeneration of Inflammatory Bone Defect'. | J Cell Mol Med | 2026 | 41545321 | PubTator, text mining | PubMed |
| <p>Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)</p>. | Int J Oncol | 2026 | 41543183 | PubTator, text mining | PubMed |
| Discovery of Novel Multifunctional Molecules for Synergistic Theranostics Based on Vascular Normalization Targets. | Mol Pharm | 2026 | 41530989 | PubTator, text mining | PubMed |
| Exploring the role of disulfidptosis‑related signatures in immune microenvironment, prognosis and therapeutic strategies of cholangiocarcinoma. | Oncol Rep | 2026 | 41480714 | PubTator, text mining | PubMed |
| Combined exome and RNA-seq analysis in patients with rare non-syndromic inherited brain arteriovenous malformation suggests a novel function for PTPN13 in arterial specification. | Thromb Res | 2026 | 41418676 | PubTator, text mining | PubMed |
| Discovery of drug target for vascular normalization through multifunctional photoaffinity probes. | Eur J Med Chem | 2026 | 41380387 | PubTator, text mining | PubMed |
| siRASA1 in vascular endothelial cells alleviates subretinal fibrosis through inhibiting macrophage-myofibroblast transdifferentiation via SHH signaling pathway. | Cell Signal | 2026 | 41270813 | PubTator, text mining | PubMed |
| Ephrin‑B2 promotes gastric cancer growth by inhibiting apoptosis and regulating the cell cycle via the Wnt/β‑catenin signaling pathway. | Int J Oncol | 2026 | 41268595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1948/papers?page=3